Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Other Non-Current Liabilities came in at $1.5 million in Q2 2026, up 56.21% year-over-year from $934000.0 in Q2 2025, and up 11.29% quarter-over-quarter from $1.3 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Other Non-Current Liabilities for 17 consecutive years, with $1.5 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 56.21% year-over-year to $1.5 million in Q2 2026; TTM through Jun 2026 was $1.5 million, a 56.21% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 76.65% from the prior year.
- Other Non-Current Liabilities was $1.5 million for Q2 2026 at Lemaitre Vascular, up from $1.3 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $2.6 million in Q1 2022 and troughed at $831000.0 in Q4 2024.
- A 5-year average of $1.8 million and a median of $2.2 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities slumped 63.36% in 2024 and jumped 76.65% in 2025, its largest moves.
- Over 5 years, Other Non-Current Liabilities stood at $2.2 million in 2022, then climbed by 4.66% to $2.3 million in 2023, then tumbled by 63.36% to $831000.0 in 2024, then jumped by 76.65% to $1.5 million in 2025, then dropped by 0.61% to $1.5 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $1.5 million (Q2 2026), $1.3 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 933,000.00 |
| Jun 30, 2025 | 934,000.00 |
| Mar 31, 2025 | 875,000.00 |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 896,000.00 |
| Jun 30, 2024 | 2.18 Mn |
| Mar 31, 2024 | 2.18 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.26 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 2.41 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 2.63 Mn |
| Dec 31, 2021 | 2.70 Mn |
| Sep 30, 2021 | 3.60 Mn |